Company Filing History:
Years Active: 2018
Title: The Innovations of Stephan Mattecka in Protein Separation Technologies
Introduction
Stephan Mattecka, an accomplished inventor based in Berlin, Germany, has significantly contributed to the field of biochemistry with his two innovative patents. His work focuses on the development of separation materials and methods for the efficient removal of biological components, particularly in medical applications.
Latest Patents
Mattecka's recent patents include a novel separation material featuring phosphoryl choline derivatives, designed to immobilize proteins on solid supports. This innovative material binds with high affinity and specificity to C-reactive protein and anti-phosphoryl choline antibodies. The application of this separation technology is particularly beneficial for the extracorporeal removal of these proteins from biological fluids, aiding in the prophylaxis and treatment of immune dysfunctions and cardiovascular diseases. Furthermore, he has developed a method utilizing citrate solutions for affinity chromatographic purification of C-reactive protein (CRP), leveraging the unique binding properties of (Ca-dependent) functionalized materials to enhance purification processes.
Career Highlights
Stephan Mattecka works with Pentracor GmbH, a company specializing in medical technologies. His dedication to research and innovation in this field has paved the way for advancements that hold promise for improving patient outcomes. With two active patents, he remains at the forefront of biotechnological innovations that enhance healthcare processes.
Collaborations
Throughout his career, Mattecka has collaborated with talented colleagues, including Ahmed Sheriff and Birgit Vogt. These collaborations have fostered a creative environment that encourages the exploration of new ideas and the development of innovative solutions in protein separation techniques.
Conclusion
Stephan Mattecka stands out as a significant contributor to the field of biochemistry through his patents that refine methods of protein separation. His work with Pentracor GmbH and enduring collaborations serve as a testament to his commitment to innovation, ultimately aimed at enhancing medical treatments for various health conditions.